应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MREO Mereo Biopharma Group Plc
交易中 12-20 13:59:07 EST
3.33
+0.04
+1.06%
最高
3.39
最低
3.11
成交量
95.26万
今开
3.28
昨收
3.29
日振幅
8.51%
总市值
5.15亿
流通市值
3.33亿
总股本
1.55亿
成交额
309.28万
换手率
0.95%
流通股本
1.00亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Mereo Biopharma Group Plc盘中异动 急速下挫5.17%
市场透视 · 12-20 23:03
Mereo Biopharma Group Plc盘中异动 急速下挫5.17%
Mereo Biopharma Group Plc盘中异动 股价大涨5.59%报3.59美元
市场透视 · 12-18 23:00
Mereo Biopharma Group Plc盘中异动 股价大涨5.59%报3.59美元
Mereo Biopharma Group Plc盘中异动 大幅跳水5.08%报3.55美元
市场透视 · 12-16
Mereo Biopharma Group Plc盘中异动 大幅跳水5.08%报3.55美元
Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.06%报3.66美元
市场透视 · 12-13
Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.06%报3.66美元
Mereo Biopharma Group Plc盘中异动 股价大涨6.63%
市场透视 · 12-06
Mereo Biopharma Group Plc盘中异动 股价大涨6.63%
Mereo Biopharma Group Plc盘中异动 急速拉升5.00%报3.57美元
市场透视 · 11-28
Mereo Biopharma Group Plc盘中异动 急速拉升5.00%报3.57美元
Mereo Biopharma Group Plc盘中异动 股价大跌5.10%报3.53美元
市场透视 · 11-26
Mereo Biopharma Group Plc盘中异动 股价大跌5.10%报3.53美元
Mereo Biopharma Group Plc2024财年第三财季实现净利润-15.15百万美元
市场透视 · 11-19
Mereo Biopharma Group Plc2024财年第三财季实现净利润-15.15百万美元
Mereo Biopharma Group Plc盘中异动 大幅下挫5.81%
市场透视 · 11-18
Mereo Biopharma Group Plc盘中异动 大幅下挫5.81%
Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.43%
市场透视 · 11-15
Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.43%
Mereo Biopharma Group Plc盘中异动 大幅下挫5.61%报4.04美元
市场透视 · 11-05
Mereo Biopharma Group Plc盘中异动 大幅下挫5.61%报4.04美元
Mereo Biopharma Group Plc盘中异动 大幅下挫5.61%报4.13美元
市场透视 · 10-23
Mereo Biopharma Group Plc盘中异动 大幅下挫5.61%报4.13美元
Mereo Biopharma Group Plc盘中异动 临近午盘股价大跌5.41%
市场透视 · 10-21
Mereo Biopharma Group Plc盘中异动 临近午盘股价大跌5.41%
Mereo Biopharma Group Plc盘中异动 早盘大幅拉升5.25%
市场透视 · 09-26
Mereo Biopharma Group Plc盘中异动 早盘大幅拉升5.25%
Mereo Biopharma Group Plc盘中异动 早盘股价大涨5.09%
市场透视 · 09-19
Mereo Biopharma Group Plc盘中异动 早盘股价大涨5.09%
异动解读 | Mereo Biopharma Group Plc股价大跌5.37% 罕见疾病治疗产品前景存疑
异动解读 · 08-20
异动解读 | Mereo Biopharma Group Plc股价大跌5.37% 罕见疾病治疗产品前景存疑
Mereo Biopharma Group Plc盘中异动 股价大跌5.37%报4.23美元
自选股智能写手 · 08-20
Mereo Biopharma Group Plc盘中异动 股价大跌5.37%报4.23美元
Mereo Biopharma Group Plc盘中异动 急速上涨5.08%
自选股智能写手 · 08-20
Mereo Biopharma Group Plc盘中异动 急速上涨5.08%
Mereo Biopharma Group Plc盘中异动 临近收盘大幅上涨5.06%报4.15美元
自选股智能写手 · 08-16
Mereo Biopharma Group Plc盘中异动 临近收盘大幅上涨5.06%报4.15美元
Mereo Biopharma Group Plc盘中异动 临近午盘大幅拉升5.05%报3.95美元
自选股智能写手 · 08-15
Mereo Biopharma Group Plc盘中异动 临近午盘大幅拉升5.05%报3.95美元
加载更多
公司概况
公司名称:
Mereo Biopharma Group Plc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Mereo BioPharma Group plc于2015年3月10日根据英格兰和威尔士法律注册成立.Mereo是一家生物制药公司,致力于创新疗法的开发和商业化,旨在改善罕见疾病患者的治疗效果。 Mereo的产品组合包括四个临床阶段候选产品,每个产品都来自大型制药公司。 Mereo正在开发用于治疗成骨不全症(“OI”)的BPS-804,用于治疗严重α-1抗胰蛋白酶缺乏症(“AATD”)的MPH-966,用于治疗慢性阻塞性肺疾病急性加重的BCT-197 疾病(“AECOPD”)和BGS-649用于治疗肥胖男性的低促性腺激素性性腺功能减退症(“HH”)。
发行价格:
--
{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":3.325,"timestamp":1734721142089,"preClose":3.29,"halted":0,"volume":952566,"delay":0,"floatShares":100155425,"shares":154898152,"eps":-0.314339,"marketStatus":"交易中","marketStatusCode":2,"change":0.035,"latestTime":"12-20 13:59:07 EST","open":3.28,"high":3.39,"low":3.11,"amount":3092824.8191232,"amplitude":0.085106,"askPrice":3.33,"askSize":700,"bidPrice":3.32,"bidSize":1356,"shortable":3,"etf":0,"ttmEps":-0.314339,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"adr":0,"listingDate":1556078400000,"adjPreClose":3.29,"adrRate":5,"preHourTrading":{"tag":"盘前","latestPrice":3.23,"preClose":3.29,"latestTime":"08:58 EST","volume":4485,"amount":14454.980085000001,"timestamp":1734703105496},"postHourTrading":{"tag":"盘后","latestPrice":3.3,"preClose":3.29,"latestTime":"18:07 EST","volume":405,"amount":1332.1087,"timestamp":1734649640569},"volumeRatio":0.968937,"impliedVol":1.0367,"impliedVolPercentile":0.6032},"requestUrl":"/m/hq/s/MREO","defaultTab":"news","newsList":[{"id":"2492447395","title":"Mereo Biopharma Group Plc盘中异动 急速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492447395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492447395?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:03","pubTimestamp":1734707031,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时03分,Mereo Biopharma Group Plc股票出现异动,股价大幅下挫5.17%。截至发稿,该股报3.12美元/股,成交量18.2793万股,换手率0.12%,振幅7.90%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.30%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220230351ab8773aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220230351ab8773aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2492187760","title":"Mereo Biopharma Group Plc盘中异动 股价大涨5.59%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492187760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492187760?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:00","pubTimestamp":1734534018,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时00分,Mereo Biopharma Group Plc股票出现异动,股价大幅拉升5.59%。截至发稿,该股报3.59美元/股,成交量68.4072万股,换手率0.44%,振幅4.85%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.49%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121823001895ea557b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121823001895ea557b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2491898697","title":"Mereo Biopharma Group Plc盘中异动 大幅跳水5.08%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491898697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491898697?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:50","pubTimestamp":1734360656,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时50分,Mereo Biopharma Group Plc股票出现异动,股价大幅下跌5.08%。截至发稿,该股报3.55美元/股,成交量7.8695万股,换手率0.05%,振幅5.88%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.81%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225056ab7c9df4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225056ab7c9df4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"gpt_icon":0},{"id":"2491330655","title":"Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.06%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491330655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491330655?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:07","pubTimestamp":1734026842,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时07分,Mereo Biopharma Group Plc股票出现异动,股价快速跳水5.06%。截至发稿,该股报3.66美元/股,成交量24.6801万股,换手率0.16%,振幅6.26%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为1.12%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213020722a1e9b15a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213020722a1e9b15a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","MREO"],"gpt_icon":0},{"id":"2489365892","title":"Mereo Biopharma Group Plc盘中异动 股价大涨6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489365892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489365892?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:30","pubTimestamp":1733495422,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时30分,Mereo Biopharma Group Plc股票出现波动,股价急速上涨6.63%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Sagimet Biosciences Inc. - Series A、Nanobiotix、Jasper Therapeutics, Inc.涨幅较大,Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为20.03%、18.48%、9.13%,振幅较大的相关个股有Jupiter Neurosciences, Inc.、Elevation Oncology, Inc.、Ovid Therapeutics Inc.,振幅分别为4.76%、3.21%、2.91%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223023971c2473&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223023971c2473&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2486726928","title":"Mereo Biopharma Group Plc盘中异动 急速拉升5.00%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486726928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486726928?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:50","pubTimestamp":1732726213,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时50分,Mereo Biopharma Group Plc股票出现异动,股价大幅拉升5.00%。截至发稿,该股报3.57美元/股,成交量15.7197万股,换手率0.10%,振幅5.00%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.36%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128005013a25a2eee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128005013a25a2eee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2486030480","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.10%报3.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486030480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486030480?lang=zh_cn&edition=full","pubTime":"2024-11-26 01:12","pubTimestamp":1732554758,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日01时12分,Mereo Biopharma Group Plc股票出现波动,股价快速跳水5.10%。截至发稿,该股报3.53美元/股,成交量44.1129万股,换手率0.28%,振幅7.66%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为1.76%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126011238abde4452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126011238abde4452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2484155559","title":"Mereo Biopharma Group Plc2024财年第三财季实现净利润-15.15百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484155559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484155559?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010416,"startTime":"0","endTime":"0","summary":"11月19日,Mereo Biopharma Group Plc公布财报,公告显示公司2024财年第三财季净利润为-15.15百万美元;其中营业收入为0.00美元,每股基本收益为-0.10美元。从资产负债表来看,Mereo Biopharma Group Plc总负债16.21百万美元,其中短期债务6.29百万美元,资产负债比为5.48,流动比率为6.11。机构评级:截至2024年11月19日,当前有5家机构对Mereo Biopharma Group Plc目标价做出预测,其中目标均价为7.20美元,其中最低目标价为6.00美元,最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180023a24561aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180023a24561aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO"],"gpt_icon":0},{"id":"2484676235","title":"Mereo Biopharma Group Plc盘中异动 大幅下挫5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676235?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:39","pubTimestamp":1731940759,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时39分,Mereo Biopharma Group Plc股票出现异动,股价大幅下跌5.81%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Hcw Biologics Inc.、冠科美博、Exicure, Inc.涨幅较大,Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃,换手率分别为536.12%、278.02%、218.58%,振幅较大的相关个股有Hcw Biologics Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、冠科美博,振幅分别为78.07%、37.19%、34.31%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822391998e43412&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822391998e43412&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4139","BK4505"],"gpt_icon":0},{"id":"2483336131","title":"Mereo Biopharma Group Plc盘中异动 下午盘股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483336131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483336131?lang=zh_cn&edition=full","pubTime":"2024-11-15 03:46","pubTimestamp":1731613601,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日03时46分,Mereo Biopharma Group Plc股票出现异动,股价大幅跳水5.43%。截至发稿,该股报3.83美元/股,成交量77.159万股,换手率0.50%,振幅7.04%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为1.09%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115034641a23871ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115034641a23871ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2481636536","title":"Mereo Biopharma Group Plc盘中异动 大幅下挫5.61%报4.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481636536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481636536?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:26","pubTimestamp":1730737616,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时26分,Mereo Biopharma Group Plc股票出现异动,股价急速下跌5.61%。截至发稿,该股报4.04美元/股,成交量15.6942万股,换手率0.10%,振幅3.62%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.31%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105002656971a436d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105002656971a436d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2477534190","title":"Mereo Biopharma Group Plc盘中异动 大幅下挫5.61%报4.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477534190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477534190?lang=zh_cn&edition=full","pubTime":"2024-10-23 23:01","pubTimestamp":1729695698,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日23时01分,Mereo Biopharma Group Plc股票出现异动,股价大幅跳水5.61%。截至发稿,该股报4.13美元/股,成交量17.6973万股,换手率0.12%,振幅4.12%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为1.21%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102323013898e3e067&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102323013898e3e067&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","MREO","BK4139"],"gpt_icon":0},{"id":"2477689842","title":"Mereo Biopharma Group Plc盘中异动 临近午盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477689842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477689842?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:30","pubTimestamp":1729524613,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时30分,Mereo Biopharma Group Plc股票出现波动,股价大幅下跌5.41%。截至发稿,该股报4.37美元/股,成交量21.5155万股,换手率0.14%,振幅6.93%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.53%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123301498e3d92b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123301498e3d92b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2470592327","title":"Mereo Biopharma Group Plc盘中异动 早盘大幅拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470592327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470592327?lang=zh_cn&edition=full","pubTime":"2024-09-26 23:24","pubTimestamp":1727364290,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日23时24分,Mereo Biopharma Group Plc股票出现波动,股价急速上涨5.25%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Pasithea Therapeutics Corp.、Nucana Plc、Kintara Therapeutics, Inc.较为活跃,换手率分别为4335.62%、157.08%、105.97%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Ocean Biomedical Inc C/Wts 14/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ,振幅分别为42.13%、40.81%、40.32%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262324519719cdbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409262324519719cdbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2468503562","title":"Mereo Biopharma Group Plc盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468503562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468503562?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:12","pubTimestamp":1726755175,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时12分,Mereo Biopharma Group Plc股票出现波动,股价大幅上涨5.09%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为1.15%。其相关个股中,Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃,换手率分别为3108.94%、572.95%、142.87%,振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为81.66%、77.53%、52.97%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919221255a1db338b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919221255a1db338b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"1182267383","title":"异动解读 | Mereo Biopharma Group Plc股价大跌5.37% 罕见疾病治疗产品前景存疑","url":"https://stock-news.laohu8.com/highlight/detail?id=1182267383","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182267383?lang=zh_cn&edition=full","pubTime":"2024-08-20 23:16","pubTimestamp":1724166981,"startTime":"0","endTime":"0","summary":"2024年8月20日,生物制药公司Mereo Biopharma Group Plc盘中股价大跌5.37%,报4.23美元。该公司主要从事开发罕见疾病创新疗法,其主打产品包括治疗成骨不全症的setrusumab,以及治疗严重α1抗胰蛋白酶缺乏相关肺部疾病的alvelestat。分析人士指出,导致Mereo Biopharma股价下跌的主要原因可能在于,其候选药物在临床试验中面临一定阻力,给未来产品前景带来不确定性。在缺乏突破性利好消息的情况下,投资者对Mereo Biopharma等小型生物制药企业的未来前景保持观望态度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MREO"],"gpt_icon":0},{"id":"2460883188","title":"Mereo Biopharma Group Plc盘中异动 股价大跌5.37%报4.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460883188","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460883188?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:57","pubTimestamp":1724165867,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时57分,Mereo Biopharma Group Plc股票出现波动,股价快速下跌5.37%。截至发稿,该股报4.23美元/股,成交量43.386万股,换手率0.28%,振幅6.26%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为0.37%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820225747a1d53de6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820225747a1d53de6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2460840051","title":"Mereo Biopharma Group Plc盘中异动 急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460840051","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460840051?lang=zh_cn&edition=full","pubTime":"2024-08-20 00:16","pubTimestamp":1724084177,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日00时16分,Mereo Biopharma Group Plc股票出现波动,股价急速拉升5.08%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为1.32%。其相关个股中,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为7188.30%、3357.42%、1046.47%,振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ,振幅分别为405.90%、220.18%、196.04%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820001617a1d507be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820001617a1d507be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2459404967","title":"Mereo Biopharma Group Plc盘中异动 临近收盘大幅上涨5.06%报4.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459404967","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459404967?lang=zh_cn&edition=full","pubTime":"2024-08-16 03:30","pubTimestamp":1723750208,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日03时30分,Mereo Biopharma Group Plc股票出现异动,股价急速拉升5.06%。截至发稿,该股报4.15美元/股,成交量99.8423万股,换手率0.65%,振幅8.51%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体涨幅为1.25%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816033008a1d47711&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816033008a1d47711&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2459010341","title":"Mereo Biopharma Group Plc盘中异动 临近午盘大幅拉升5.05%报3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459010341","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459010341?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:00","pubTimestamp":1723651235,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时00分,Mereo Biopharma Group Plc股票出现异动,股价快速拉升5.05%。截至发稿,该股报3.95美元/股,成交量69.7269万股,换手率0.45%,振幅6.91%。Mereo Biopharma Group Plc股票所在的生物技术行业中,整体跌幅为0.29%。Mereo Biopharma Group Plc公司简介:Mereo BioPharma Group PLC 是一家总部位于英国的生物制药公司,专注于开发罕见疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081500003698e34f47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081500003698e34f47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MREO","BK4139","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.118},{"period":"1month","weight":-0.0573},{"period":"3month","weight":-0.2259},{"period":"6month","weight":-0.1734},{"period":"1year","weight":0.6533},{"period":"ytd","weight":0.4242}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mereo BioPharma Group plc于2015年3月10日根据英格兰和威尔士法律注册成立.Mereo是一家生物制药公司,致力于创新疗法的开发和商业化,旨在改善罕见疾病患者的治疗效果。 Mereo的产品组合包括四个临床阶段候选产品,每个产品都来自大型制药公司。 Mereo正在开发用于治疗成骨不全症(“OI”)的BPS-804,用于治疗严重α-1抗胰蛋白酶缺乏症(“AATD”)的MPH-966,用于治疗慢性阻塞性肺疾病急性加重的BCT-197 疾病(“AECOPD”)和BGS-649用于治疗肥胖男性的低促性腺激素性性腺功能减退症(“HH”)。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.004235},{"month":2,"riseRate":0.6,"avgChangeRate":0.086714},{"month":3,"riseRate":0,"avgChangeRate":-0.201006},{"month":4,"riseRate":0.6,"avgChangeRate":0.139061},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.112584},{"month":6,"riseRate":0.666667,"avgChangeRate":0.423047},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.001741},{"month":8,"riseRate":0.833333,"avgChangeRate":0.120541},{"month":9,"riseRate":0,"avgChangeRate":-0.151475},{"month":10,"riseRate":0.5,"avgChangeRate":0.093197},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.115669},{"month":12,"riseRate":0.5,"avgChangeRate":0.121635}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mereo Biopharma Group Plc(MREO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mereo Biopharma Group Plc(MREO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}